Cresco Labs Inc.
CL
CNSX
Weiss Ratings | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.10 | |||
Price History | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 7.56% | |||
30-Day Total Return | 0.79% | |||
60-Day Total Return | -15.79% | |||
90-Day Total Return | -41.82% | |||
Year to Date Total Return | -6.57% | |||
1-Year Total Return | -39.62% | |||
2-Year Total Return | -50.39% | |||
3-Year Total Return | -81.64% | |||
5-Year Total Return | -75.71% | |||
52-Week High % Change | -67.32% | |||
52-Week Low % Change | 11.43% | |||
Price | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.58 | |||
52-Week Low Price | $1.05 | |||
52-Week Low Price (Date) | Mar 04, 2025 | |||
52-Week High Price (Date) | Apr 30, 2024 | |||
Valuation | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 281.20M | |||
Enterprise Value | 696.01M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.20 | |||
Earnings Per Share Growth | -81.89% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.56 | |||
Price/Book (Q) | 0.89 | |||
Enterprise Value/Revenue (TTM) | 0.96 | |||
Price | $1.28 | |||
Enterprise Value/EBITDA (TTM) | 3.79 | |||
Enterprise Value/EBIT | 5.88 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 347.36M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -0.30% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 312 410 8226 | |||
Address | 400 West Erie Street Chicago, IL 60654 | |||
Website | www.crescolabs.com | |||
Country | United States | |||
Year Founded | 1990 | |||
Profitability | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 16.29% | |||
Profit Margin | -9.28% | |||
Management Effectiveness | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 5.32% | |||
Return on Equity | -- | |||
Income Statement | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 726.35M | |||
Total Revenue (TTM) | 726.35M | |||
Revenue Per Share | $2.09 | |||
Gross Profit (TTM) | 366.26M | |||
EBITDA (TTM) | 183.77M | |||
EBIT (TTM) | 118.33M | |||
Net Income (TTM) | -67.43M | |||
Net Income Avl. to Common (TTM) | -67.43M | |||
Total Revenue Growth (Q YOY) | -4.53% | |||
Earnings Growth (Q YOY) | 93.22% | |||
EPS Diluted (TTM) | -0.20 | |||
EPS Diluted Growth (Q YOY) | 91.15% | |||
Balance Sheet | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 153.30M | |||
Cash Per Share (Q) | $0.44 | |||
Total Current Assets (Q) | 311.92M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 365.37M | |||
Current Ratio (Q) | 1.967 | |||
Book Value Per Share (Q) | $1.31 | |||
Total Assets (Q) | 1.38B | |||
Total Current Liabilities (Q) | 158.57M | |||
Total Debt (Q) | 690.45M | |||
Total Liabilities (Q) | 1.02B | |||
Total Common Equity (Q) | 456.88M | |||
Cash Flow | CL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -19.61M | |||
Cash from Financing (TTM) | -33.23M | |||
Net Change in Cash (TTM) | 46.79M | |||
Levered Free Cash Flow (TTM) | 70.14M | |||
Cash from Operations (TTM) | 99.69M | |||